Altrius Capital Management Inc Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Altrius Capital Management Inc boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,862 shares of the biopharmaceutical company’s stock after buying an additional 728 shares during the period. Altrius Capital […]
More Stories
Critical Comparison: Solaris Energy Infrastructure (NASDAQ:SEI) versus Drilling Tools International (NASDAQ:DTI)
Drilling Tools International (NASDAQ:DTI – Get Free Report) and Solaris Energy Infrastructure (NASDAQ:SEI – Get Free Report) are both small-cap...
The Role of Analytics in Online Radio Station Software
In today’s technology-driven era, where the digital landscape transforms how people interact with media content, radio stations have become a...
EOR or In-House HR to Handle Global Employment?
Venturing into global markets is an exciting yet challenging prospect for many businesses. Strategic HR decisions can help hugely influence...
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine...
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Recommendation of “Buy” by Analysts
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Buy” from the thirteen...
APi Group Co. (NYSE:APG) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of APi Group Co. (NYSE:APG – Get Free Report) have been given a consensus rating of “Moderate Buy” by...